Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A unique need that CDMOs are looking to meet is the seasonal availability requirement for mRNA vaccines
However, they are generally considered safe, with fewer side effects than some other treatments
Once approved, patients receive their prescription and support plan
Treatment with the selective GLS1 inhibitor BPTES reduced glycolysis and ameliorated lupus-like disease and EAE in MRL/lpr mice ( + CD4 - CD8 - cells), the urinary albumin/creatinine ratio, glomerular nephropathy score, and T-cell infiltration with IL-17A in the kidneys, relieving the EAE disease activity ( + T cells by inhibiting GLS1, glycolysis, and CD4 + T-cell differentiation in vitro by reducing the level of HIF1 protein, a key metabolic sensor in Th17 cells ( Table 1 )
US$ 25.64
US$ 20.33
US$ 21.55
US$ 25.88
US$ 24.56
US$ 22.42
US$ 20.28
US$ 26.51
US$ 24.42
US$ 27.83
